Application 020831
- Type
- NDA
- Sponsor
- NOVARTIS
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | FORADIL | FORMOTEROL FUMARATE | POWDER;INHALATION | 0.012MG/INH | Yes | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N020831-001 | FORADIL | FORMOTEROL FUMARATE | 0.012MG/INH **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | POWDER / INHALATION | RLD | 2001-02-16 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | N020831-001 | FORADIL | 0.012MG/INH | POWDER / INHALATION | RLD | 2001-02-16 | 3a93d1ddd44b… | |
| 2022-10-28 04:53 UTC | 2022-10 | N020831-001 | FORADIL | 0.012MG/INH | POWDER / INHALATION | RLD | 2001-02-16 | f41ea6bd6efb… | |
| 2022-09-29 23:25 UTC | 2022-09 | N020831-001 | FORADIL | 0.012MG/INH | POWDER / INHALATION | RLD | 2001-02-16 | e64feba35796… | |
| 2022-07-09 03:26 UTC · 3 captures of this ZIP | 2022-07 | N020831-001 | FORADIL | 0.012MG/INH | POWDER / INHALATION | RLD | 2001-02-16 | cb3db0bc1861… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | N020831-001 | FORADIL | 0.012MG/INH **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | POWDER / INHALATION | RLD | 2001-02-16 | a50c72e98297… |
Observed Orange Book patent history#
| Captured | Edition | Application-product | Patent | Expiration | Use code | Coverage / status | Submission date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|
| 2019-12-13 00:20 UTC | 2019-12 | N020831-001 | 6488027 | 2019-03-08 | 74a2ff9319b5… | |||
| 2019-12-13 00:20 UTC | 2019-12 | N020831-001 | 6887459 | 2020-11-28 | U-762 | 74a2ff9319b5… | ||
| 2020-12-22 03:56 UTC | 2020-12 | N020831-001 | 6887459 | 2020-11-28 | U-762 | 8869cabd3fbd… | ||
| 2020-11-12 02:37 UTC | 2020-11 | N020831-001 | 6887459 | 2020-11-28 | U-762 | c0c555d07b60… | ||
| 2019-12-14 00:12 UTC | 2019-12 | N020831-001 | 6488027 | 2019-03-08 | 3f01610625f2… | |||
| 2019-12-14 00:12 UTC | 2019-12 | N020831-001 | 6887459 | 2020-11-28 | U-762 | 3f01610625f2… | ||
| 2019-09-15 20:21 UTC | 2019-09 | N020831-001 | 6488027 | 2019-03-08 | b00525d2431f… | |||
| 2019-09-15 20:21 UTC | 2019-09 | N020831-001 | 6887459 | 2020-11-28 | U-762 | b00525d2431f… | ||
| 2019-07-19 19:46 UTC | 2019-07 | N020831-001 | 6488027 | 2019-03-08 | ea99ee380514… | |||
| 2019-07-19 19:46 UTC | 2019-07 | N020831-001 | 6887459 | 2020-11-28 | U-762 | ea99ee380514… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Formoterol Fumarate | FORMOTEROL FUMARATE | Alembic Pharmaceuticals Inc. | 07afdf7e-c480-4806-b469-a6a460522bc0 | 2025-12-23 | Warnings, Adverse reactions | FORMOTEROL FUMARATE |
| Formoterol Fumarate | FORMOTEROL FUMARATE | Ingenus Pharmaceuticals, LLC | 303479a7-80fb-1f6d-e063-6394a90abbda | 2025-06-05 | Warnings, Adverse reactions | FORMOTEROL FUMARATE |
| Formoterol Fumarate | FORMOTEROL FUMARATE | Dr. Reddy's Laboratories Inc. | 2010b5cb-c277-57dd-ed6b-607cad2c45a4 | 2025-01-30 | Warnings, Adverse reactions | FORMOTEROL FUMARATE |
| formoterol fumarate | FORMOTEROL FUMARATE | Lupin Pharmaceuticals, Inc. | 44284e8c-0503-48c4-ae71-a0d6b865665d | 2025-01-13 | Warnings, Adverse reactions | FORMOTEROL FUMARATE |
| Formoterol fumarate | FORMOTEROL FUMARATE | Micro Labs Limited | 0796acea-70d6-479f-af48-18723b1efd2a | 2024-09-26 | Warnings, Adverse reactions | FORMOTEROL FUMARATE |
| Formoterol fumarate | FORMOTEROL FUMARATE | Bryant Ranch Prepack | d8f7c5ff-bd3c-4eab-b58a-1e3a478e5879 | 2024-01-11 | Warnings, Adverse reactions | FORMOTEROL FUMARATE |
| Formoterol fumarate | FORMOTEROL FUMARATE | Bryant Ranch Prepack | 9786f3e2-4265-4246-9999-f73cd6b33fc8 | 2024-01-11 | Warnings, Adverse reactions | FORMOTEROL FUMARATE |
| Formoterol fumarate | FORMOTEROL FUMARATE | Teva Pharmaceuticals USA, Inc. | 419bc85d-8e24-478b-921e-babfb73e79f3 | 2020-10-31 | Warnings, Adverse reactions | FORMOTEROL FUMARATE |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Documents#
| Document | Submission type | Date |
|---|---|---|
| 25978 | SUPPL | 2013-04-01 |
| 25977 | SUPPL | 2013-04-01 |
| 3482 | SUPPL | 2012-10-02 |
| 13545 | SUPPL | 2012-09-28 |
| 3481 | SUPPL | 2012-03-26 |
| 13544 | SUPPL | 2012-03-23 |
| 3479 | SUPPL | 2011-05-25 |
| 3480 | SUPPL | 2011-05-06 |
| 35459 | SUPPL | 2011-05-05 |
| 25976 | SUPPL | 2011-02-14 |
| 25975 | SUPPL | 2010-06-03 |
| 35458 | SUPPL | 2010-06-02 |
| 43681 | ORIG | 2009-11-19 |
| 41737 | SUPPL | 2007-07-09 |
| 35457 | SUPPL | 2006-06-20 |
| 3478 | SUPPL | 2006-06-20 |
| 3476 | SUPPL | 2004-06-04 |
| 23603 | ORIG | 2003-12-09 |
| 13543 | SUPPL | 2003-07-08 |
| 3477 | SUPPL | 2003-07-06 |
| 35456 | SUPPL | 2003-04-24 |
| 41736 | ORIG | 2001-02-16 |
| 25974 | ORIG | 2001-02-16 |
| 13542 | ORIG | 2001-02-16 |